Zhitong Finance App News, Aimeike (300896.SZ) announced that the company's exclusive distribution of injectable type A botulinum toxin products produced by South Korea's Huons BP in China has obtained the “Drug Registration Certificate” approved and issued by the State Drug Administration.

Zhitongcaijing · 3d ago
Zhitong Finance App News, Aimeike (300896.SZ) announced that the company's exclusive distribution of injectable type A botulinum toxin products produced by South Korea's Huons BP in China has obtained the “Drug Registration Certificate” approved and issued by the State Drug Administration.